COVID-19
mRNA vaccines - here's everything you need to know
What's inside an mRNA vaccine vial? How do mRNA vaccines differ from other approaches, and what’s their promise for the future?
Elissa Prichep
Elissa spent the past 12 years launching specialty therapeutics and initiatives in the bio-pharmaceutical industry and developing economic policy in the public sector. She most recently lead patient strategy and digital innovation for biosimilar immunology products at Merck, brought their ground-breaking immunotherapy cancer treatment to market and developed their first 24/7 patient support program. Elissa earned her MBA as a Woodruff Fellow at Emory University and her B.A. from Cornell University.
Most Popular
GTGS2021
Realizing the potential of synthetic biology to help people and the planet
Members of the World Economic Forum's Global Future Council explore what's needed to realize synthetic biology's potential - and why we'll need to revisit and rethink the societal transfo...
The Davos Agenda 2021
Learning lessons from across Europe – the hidden costs of COVID-19 on lung cancer
The World Economic Forum, in partnership with the Lung Ambition Alliance, establishes a taskforce to learn from impact of COVID-19 on lung cancer services.
The Davos Agenda 2021
Are vaccines enough? To end COVID-19 we need more innovation – and more access
New alliances are needed to speed the journey of medical innovations from the scientist’s bench to the patient’s bedside across all countries.
Precision Medicine
This is how to address genomic data abuse to achieve health equity
A new framework balances ethical tensions to ensure equitable health outcomes globally.
COVID-19
Why a coronavirus vaccine takes over a year to produce – and why that is incredibly fast
In the race to develop a coronavirus vaccine, the public is repeatedly reminded that the finish line is at least 12 to 18 months away. Here's why.
Precision Medicine
Precision medicine should be accessible to all
Countries across the world are realizing that targetted approaches to disease screening and treatment are the future of their healthcare systems.
Rwanda
Le Rwanda peut-il devenir le pays leader de la santé en Afrique ?
Le Rwanda fournit des vaccins gratuits contre le virus du papillome humain (VPH) à toutes les filles de 11 à 15 ans et a maintenant immunisé plus de 97 % des filles
Global Health
¿Podría Ruanda convertirse en líder en el ámbito sanitario de África?
En la actualidad, mueren más africanos de cáncer que de malaria. Muchos países africanos están luchando contra el aumento de las tasas de enfermedades no transmisibles (ENT).
Precision Medicine
Could Rwanda become Africa's healthcare leader?
The African country has introduced a basic universal health insurance for over 90% of its population, and is using technology to innovate and transform its healthcare system.
Precision Medicine
Here are 4 ways precision medicine could impact you
Thanks to more personalized healthcare, you will soon spend less time in doctors’ offices, have more peace of mind knowing what is wrong, and experience fewer side effects from trial-and-...